Delete

Are you sure you want to delete this?

Proposal_Info
Status
Awarded
Identifier
00-21
Date of Proposal
7/26/1999
Action Date
7/21/1999
Funding Agency
Bayer Corporation
Title
Moxifloxacin Regional and National In-Vitro Susceptibility of Common Respiratory Tract Pathogens (MSP)
Keyword_1
Fluoroquinolones
Keyword_2
Respiratory Tract
Keyword_3
Susceptibility
Type
New
Type of Award
Grant
Type of Project
Research
Start Date
7/1/1999
End Date
11/30/1999
Requested Amount
$5,000.00
Indirect Amount Requested
$0.00
Indirect Costs
Cost Share/Match
Release Time Requested
Human Subjects Involved
Animals Involved
Hazardous Chemicals Involved
Radiation Involved
Biohazards and/or Recombinant DNA/RNA Molecules
Real or Potential Conflict of Interest
New Program/Degree/Major
Future Equipment Maintenance Needed
Consultants or Subcontractors
Lobbying
Construction or Facilities Modification

| Back to List